CD79A and systemic lupus erythematosus: Treatment with RZ-I reduced the level of proteinuria, inhibited the production of anti-DNA, and there was no glomerular IgG, IgM, or IgA deposition in humanized SLE mice (SCID mice engrafted with 0.5×107 PBLs/mouse from patients with SLE) (17).